Tirzepatide is a dual GIP/GLP-1 receptor agonist licensed in the UK for type 2 diabetes and, under specific NICE criteria, for weight management
With our support and guidance, you'll gain the knowledge and tools necessary to achieve sustainable weight loss and improve your overall health and well-being
GLP-1, or glucagon-like peptide 1, is a hormone that targets areas of the brain that regulate appetite and food intake
Ghosh S, Alex LE, Khan F, Das J, Biswas T, Basu S, Basak P, Nag A, Thakur AR, Sudarshan M, Ulrich C
Additionally, its ability to reduce stress by stabilizing the hypothalamic-pituitary-adrenal (HPA) axis and lowering cortisol levels may further alleviate depressive symptoms (3)
Meng ZL, Chen F, Zhao F, Gu HL, Zheng Y